Searched for
OCUGEN INC
Ocugen-Bharat Biotech COVID vaccine meets main goals in U.S. trialCovaxin is not cleared for use in any age group in the United States, but is one of the two most widely used COVID vaccines in India and ha...- Covaxin's clinical trials can resume in US as FDA lifts holdThe FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a temporary pa...
- Bharat Biotech, Ocugen committed to bring COVID-19 vaccine Covaxin in US, CanadaLast month, Bharat Biotech had announced that Covaxin would be assessed in the United States as a COVID-19 vaccine candidate.
- Study shows booster dose of Covaxin has neutralising effect on Omicron, Delta variants: Bharat BiotechThe study conducted at Emory University demonstrated that subjects who received a booster dose of Covaxin (BBV152) six months after getting...
- Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trialsThe US firm in a press release said the Phase 3 trial, proposed in the IND, is designed to establish whether the immune response experience...
- Bharat Biotech's partner Ocugen seeks approval for Covaxin in CanadaThe move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 a...
- Bharat Biotech ties up with Ocugen to commercialise Covaxin in CanadaUnder the agreement, Ocugen will have the US rights to the vaccine candidate and will be responsible for clinical development, regulatory a...
- America denying EUA to Covaxin won't impact India's vaccine programme, says governmentResponding to a question on the denial to Covaxin, NITI Aayog member (Health) V K Paul said each country has its own regulatory system whic...
- FDA rejects EUA for Covaxin, 'suggests' Biologics Licence Application route for approval in USOcugen in a statement on Thursday announced that as recommended by theFDA,it will pursue submission of a biologics licence application (BLA...
- Ocugen to file for full US approval of COVID-19 shot Covaxin instead of EUAOcugen said the decision was based on a recommendation from the U.S. Food and Drug Administration (FDA), which also requested more informat...
- S&P 500 hits record high as Wall Street brushes off higher inflation dataA bigger-than-expected jump in May consumer prices raised concerns of early policy tightening by the Federal Reserve, while another report ...
- Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in CanadaThe Indian biotech company and Ocugen Inc have entered into a definitive agreement to co-develop, supply, and commercialise Covaxin for the...
- Bharat Biotech's American partner Ocugen submits 'Master File' to FDA on CovaxinOcugen has submitted key information and data to date including preclinical studies, chemistry, manufacturing, and controls (CMC), and clin...
- New meme stocks swing as shorts and retail investors face off againStocks that have notched big swings this month include laser-manufacturer MicroVision Inc, a favorite on Reddit’s popular WallStreetBets fo...
- Ocugen seeks to sell 100 million doses of Bharat Biotech's Covaxin in US in 2021The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the s...
- Bharat Biotech pursues COVID-19 vaccine approval in over 40 countries"We have submitted our documentation in Brazil and other countries and await their approval. We plan to export several million doses to Bra...
- Bharat Biotech, Ocugen sign pact for supply of Covaxin to US marketThe companies have entered into a definitive agreement for Covaxin, an advanced stage whole-virion inactivated COVID-19 vaccine candidate, ...
- India's approval of homegrown vaccine criticised over lack of dataThe government also approved the use of a vaccine developed by AstraZeneca and Oxford University which will be the lead vaccine in India's ...
- Timeline: How India's coronavirus vaccine got approved by drugs expertsCOVAXIN has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Resea...
- Bharat Biotech, Ocugen to co-develop Covaxin for US marketAs per the letter of intent (LOI), "Ocugen will have US rights to the vaccine candidate and, in collaboration with Bharat Biotech, will be ...
Load More
